Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Research
You have accessRestricted Access

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

Carmen Lefaucheur, Alexandre Loupy, Gary S. Hill, Joao Andrade, Dominique Nochy, Corinne Antoine, Chantal Gautreau, Dominique Charron, Denis Glotz and Caroline Suberbielle-Boissel
JASN August 2010, 21 (8) 1398-1406; DOI: https://doi.org/10.1681/ASN.2009101065
Carmen Lefaucheur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre Loupy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary S. Hill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joao Andrade
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Nochy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinne Antoine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chantal Gautreau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Charron
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Glotz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Suberbielle-Boissel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

The clinical importance of preexisting HLA antibodies at the time of transplantation, identified by contemporary techniques, is not well understood. We conducted an observational study analyzing the association between preexisting donor-specific HLA antibodies (HLA-DSA) and incidence of acute antibody-mediated rejection (AMR) and survival of patients and grafts among 402 consecutive deceased-donor kidney transplant recipients. We detected HLA-DSA using Luminex single-antigen assays on the peak reactive and current sera. All patients had a negative lymphocytotoxic cross-match test on the day of transplantation. We found that 8-year graft survival was significantly worse (61%) among patients with preexisting HLA-DSA compared with both sensitized patients without HLA-DSA (93%) and nonsensitized patients (84%). Peak HLA-DSA Luminex mean fluorescence intensity (MFI) predicted AMR better than current HLA-DSA MFI (P = 0.028). As MFI of the highest ranked HLA-DSA detected on peak serum increased, graft survival decreased and the relative risk for AMR increased: Patients with MFI >6000 had >100-fold higher risk for AMR than patients with MFI <465 (relative risk 113; 95% confidence interval 31 to 414). The presence of HLA-DSA did not associate with patient survival. In conclusion, the risk for both AMR and graft loss directly correlates with peak HLA-DSA strength. Quantification of HLA antibodies allows stratification of immunologic risk, which should help guide selection of acceptable grafts for sensitized patients.

Footnotes

  • C.S.-B. and D.G. contributed equally to this work.

  • Copyright © 2010 by the American Society of Nephrology
View Full Text
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 21 (8)
Journal of the American Society of Nephrology
Vol. 21, Issue 8
1 Aug 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Carmen Lefaucheur, Alexandre Loupy, Gary S. Hill, Joao Andrade, Dominique Nochy, Corinne Antoine, Chantal Gautreau, Dominique Charron, Denis Glotz, Caroline Suberbielle-Boissel
JASN Aug 2010, 21 (8) 1398-1406; DOI: 10.1681/ASN.2009101065

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
Carmen Lefaucheur, Alexandre Loupy, Gary S. Hill, Joao Andrade, Dominique Nochy, Corinne Antoine, Chantal Gautreau, Dominique Charron, Denis Glotz, Caroline Suberbielle-Boissel
JASN Aug 2010, 21 (8) 1398-1406; DOI: 10.1681/ASN.2009101065
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Concise Methods
    • Disclosures
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis
  • Molecular Characterization of Membranous Nephropathy
  • Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study
Show more Clinical Research

Cited By...

  • A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
  • Pretransplant Kinetics of Anti-HLA Antibodies in Patients on the Waiting List for Kidney Transplantation
  • Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study
  • Removal of Non-specific Reactions of LABScreen Single Antigen Class II Assay by Fetal Bovine Serum Treatment
  • A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection
  • Predicting humoral alloimmunity from differences in donor-recipient HLA surface electrostatic potential
  • Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential
  • Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival
  • Precision Transplant Medicine: Biomarkers to the Rescue
  • Being Thoughtful about Desensitization
  • Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients
  • Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation
  • Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection
  • Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss
  • Approach to the Highly Sensitized Kidney Transplant Candidate
  • Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
  • IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury
  • The Complement System and Antibody-Mediated Transplant Rejection
  • Risk Stratification for Rejection and Infection after Kidney Transplantation
  • Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection
  • Determinants and Outcomes of Accelerated Arteriosclerosis: Major Impact of Circulating Antibodies
  • Marginal kidneys for transplantation
  • Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study
  • Utility of HLA Antibody Testing in Kidney Transplantation
  • Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts
  • Detection of C3d-Binding Donor-Specific Anti-HLA Antibodies at Diagnosis of Humoral Rejection Predicts Renal Graft Loss
  • Eculizumab to Treat Antibody-Mediated Rejection in a 7-Year-Old Kidney Transplant Recipient
  • Molecular Microscope Strategy to Improve Risk Stratification in Early Antibody-Mediated Kidney Allograft Rejection
  • Effector Mechanisms of Rejection
  • Effect of Red Cell Transfusions on Future Kidney Transplantation
  • The Clinical Impact of Humoral Immunity in Pediatric Renal Transplantation
  • Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes
  • Donor-Specific Antibodies after Ceasing Immunosuppressive Therapy, with or without an Allograft Nephrectomy
  • Desensitization Protocols and Their Outcome
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire